ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage

Current Biology

Volumn 8, Issue 3, 1998, Pages 145-155

  Aladjem, Mirit I ^a   Spike, Benjamin T ^a   Rodewald, Luo Wei ^a   Hope, Thomas J ^a   Klemm, Martina ^b   Jaenisch, Rudolf ^b   Wahl, Geoffrey M ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032576768     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70061-2     Document Type: Article

References (79)

1. Rice GC, Hoy TD, Schimke RT: Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 1986, 83:5978-5982.
2. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 1992, 70:923-35.
3. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992, 70:937-948.
4. Brown PC, Tlsty TD, Schimke RT: Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea. Mol Cell Biol 1983, 3:1097-1107.
5. Hartwell LH, Weinert TA: Checkpoints: controls that ensure the order of cell cycle events. Science 1989, 246:629-634.
6. Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM: A reversible p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996, 10:934-947.
7. Enoch T, Carr AM, Nurse P: Fission yeast genes involved in coupling mitosis to completion of DNA replication. Genes Dev 1992, 6:2035-2046.
8. Weinert TA, Kiser GL, Hartwell LH: Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev 1994, 8:652-665.
9. Kaufmann WK, Kaufman DG: Cell cycle control, DNA repair and initiation of carcinogenesis. FASEB J 1993, 7:1188-1191.
10. Norimura T, Nomoto S, Katsuki M, Gondo Y, Kondo S: p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat Med 1996, 2:577-580.
11. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994, 266:1821-1828.
12. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL, Wells PG: A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet 1995, 10:181-187.
13. Wahl GM, Linke SP, Paulson TG, Huang L-C: Maintaining genetic stability through p53 mediated checkpoint control. In Cancer Surveys. Edited by Kastan MB. New York: Cold Spring Harbor Laboratory Press; 1997: 183-219.
14. Hansen R, Oren M: p53: from inductive signal to cellular effect. Curr Opin Genet Dev 1997, 7:46-51.
15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311.
16. Kastan MB: Signalling to p53: where does it all start? Bioessays 1996, 18:617-619.
17. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al.: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69:119-128.
18. Wagner AJ, Kokontis JM, Hay N: Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 1994, 8:2817-2830.
19. Fukasawa K, Vande WG: Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol 1997, 17:506-518.
20. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, et al.: A p53-dependent mouse spindle checkpoint. Science 1995, 267:1353-1356.
21. Minn AJ, Boise LH, Thompson CB: Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 1996, 10:2621-2631.
22. Di Leonardo A, Hussain-Khan S, Linke SP, Greco V, Seidita G, Wahl GM: DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res 1997, 57:1013-1019.
23. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CJ, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
24. Harvey M, Sands A, Weiss R, Hegi M, Wiseman R, Pantazis P, et al.: In vitro growth characteristics of embryo fibroblasts islolated from p53-deficient mice. Oncogene 1993, 8:2457-2467.
25. Symonds H, Krall L, Remington L, Saenz RM, Lowe S, Jacks T, Van DT: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994, 78:703-711.
26. Almasan A, Yin Y, Kelly R, Lee E, Bradley A, Li W, et al.: Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995, 92:5436-5440.
27. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82:675-84.
28. Li W, Fan J, Hochhauser D, Banerjee D, Zielinski Z, Almasan A, et al.: Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc Natl Acad Sci USA 1995, 92:10436-10440.
29. Di Leonardo A, Linke SP, Clarkin K, Wahl GM: DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 1994, 8:2540-2551.
30. Chang WP, Little JB: Delayed reproductive death as a dominant phenotype in cell clones surviving X-irradiation. Carcinogenesis 1992, 13:923-928.
31. Nagasawa H, Li CY, Maki CG, Imrich AC, Little JB: Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells. Cancer Res 1995, 55:1842-1846.
32. Linke SP, Clarkin KC, Wahl GM: p53 mediates permanent arrest over multiple cell cycles in response to gamma irradiation. Cancer Res 1997, 57:1171-1179.
33. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993, 362:849-852.
34. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849.
35. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH: p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 1994, 9:1767-1773.
36. Girinsky T, Koumenis C, Graeber TG, Peehl DM, Giaccia AJ: Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 1995, 55:3726-3731.
37. MacCallum DE, Hupp TR, Midgley CA, Stuart D, Campbell SJ, Harper A, et al.: The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 1996, 13:2575-2587.
38. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, et al.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992, 71:587-597.
39. Abbondanzo SJ, Gadi I, Stewart CL: Derivation of embryonic stem cell lines. Methods Enzymol 1993, 225:803-823.
40. Schmid P, Lorenz A, Hameister H, Montenarh M: Expression of p53 during mouse embryogenesis. Development 1991, 113:857-865.
41. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
42. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al.: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54:1169-1174.
43. Perry ME, Piette J, Zawadzki JA, Harvey D, Levine AJ: The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci USA 1993, 90:11623-11627.
44. Barak Y, Juven T, Haffner R, Oren M: Mdm2 expression is induced by wild type p53 activity. EMBO J 1993, 12:461-468.
45. Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
46. Kubbutat MH, Vousden KH: Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 1997, 17:460-468.
47. Shvarts A, Steegenga WT, Riteco N, van LT, Dekker P, Bazuine M, et al.: MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J 1996, 15:5349-5357.
48. Savatier P, Lapillonne H, van GL, Rudkin BB, Samarut J: Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 1996, 12:309-322.
49. Martinez J, Georgoff I, Martinez J, Levine AJ: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 1991, 5:151-159.
50. Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V: Nuclear localization is essential for the activity of p53 protein. Oncogene 1991, 6:2055-2065.
51. Wills K, Maneval D, Menzel P, Harris M, Sutjipto S, Vaillancourt M, et al.: Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther 1994, 5:1079-1088.
52. Bortner CD, Oldenburg NBE, Cidlowskj JA: The role of DNA fragmentation in apoptosis. Trends Cell Biol 1995, 5:21-26.
53. Snow BH: Gastrulation in the mouse: growth and regionalization of the epiblast. J Embryol Exp Morph 1977, 42:293-303.
54. Edgar BA, Lehner CF: Developmental control of cell cycle regulators: a fly's perspective. Science 1996, 274:1646-1652.
55. Kimelman D, Kirschner M, Scherson T: The events of the midblastula transition in Xenopus are regulated by changes in the cell cycle. Cell 1987, 48:399-407.
56. Savatier P, Huang S, Szekely L, Wiman KG, Samarut J: Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 1994, 9:809-818.
57. Li Y, Jenkins CW, Nichols MA, Xiong Y: Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994, 9:2261-2268.
58. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991, 353:345-347.
59. Wu X, Levine AJ: p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994, 91:3602-3606.
60. Sabbatini P, Lin J, Levine AJ, White E: Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 1995, 9:2184-2192.
61. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994, 371:72-74.
62. Strasser A, Harris AW, Jacks T, Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994, 79:329-339.
63. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al.: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997, 90:809-819.
64. Macleod KF, Hu Y, Jacks T: Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 1996, 15:6178-6188.
65. Hsieh JK, Fredersdorf S, Kouzarides T, Martin K, Lu X: E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 1997, 11:1840-1852.
66. Phillips AC, Bates S, Ryan KM, Helin K, Vousden KH: Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev 1997, 11:1853-1863.
67. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK, Israel MA: Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995, 14:461-472.
68. Hunt T, Kirschner M: Cell multiplication. Curr Opin Cell Biol 1993, 5:163-5.
69. Murray AW, Kirschner MW: Cyclin synthesis drives the early embryonic cell cycle. Nature 1989, 339:275-280.
70. Fisher DL, Nurse P: A single fission yeast mitotic cyclin B p34cdc2 kinase promotes both S-phase and mitosis in the absence of G1 cyclins. EMBO J 1996, 15:850-860.
71. Oren M, Reich NC, Levine AJ: Regulation of the cellular p53 tumor antigen in teratocarcinoma cells and their differentiated progeny. Mol Cell Biol 1982, 2:443-449.
72. Louis JM, McFarland VW, May P, Mora PT: The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim Biophys Acta 1988, 950:395-402.
73. Oren M, Maltzman W, Levine AJ: Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1981, 1:101-110.
74. Jones SN, Roe AE, Donehower LA, Bradley A: Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995, 378:206-208.
75. Lutzker SG, Levine AJ: A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nature Med 1996, 2:804-810.
76. Mayo LD, Berberich SJ: Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation. Oncogene 1996, 13:2315-2321.
77. Huang TH, Laux DE, Hamlin BC, Tran P, Tran H, Lubahn DB: Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique. Cancer Res 1997, 57:1030-1034.
78. Jones SN, Sands AT, Hancock AR, Vogel H, Donehower LA, Linke SP, et al.: Absence of a p53-independent role for Mdm2 in control of cell growth and tumorigenesis. Proc Natl Acad Sci USA 1996, 93:14106-14111.
79. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K: Current Protocols in Molecular Biology. New York: Greene Publishing Associates and Wiley-Interscience; 1994.